Company

Ibere Pharmaceuticals

Headquarters: Philadelphia, PA, United States

CEO: Mr. Osagie O. Imasogie Esq.

NYSE: IBER

Ibere Pharmaceuticals Categories

United States Financials Shell Companies
United States Financials United States Shell Companies

Top Competitors by Market Capitalization

Industry: Shell Companies
Company Market Cap (USD)
Spartan Energy Acquisition Corp $6.82 B
Pershing Square Tontine Holdings, Ltd. $4.03 B
Soaring Eagle Acquisition Corp $2.46 B
Austerlitz Acquisition Corp II $1.97 B
Thoma Bravo Advantage $1.77 B
Sector:
Company Market Cap (USD)
Berkshire Hathaway $887.16 B
JPMorgan $599.29 B
Visa $550.38 B
Mastercard $416.63 B
Bank of America $316.02 B

Detailed Description

Ibere Pharmaceuticals focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Ibere Pharmaceuticals has the following listings and related stock indices.


Stock: NYSE: IBER wb_incandescent

Details

Headquarters:

2005 Market Street

Suite 2030

Philadelphia, PA 19103

United States

Phone: 267-765-3222